Formulation and in vitro evaluation of buoyant controlled release lercanidipine lipospheres

Journal of Microencapsulation

Volumn 26, Issue 7, 2009, Pages 635-641

  Pandit, Sachin S ^a   Patil, Arun T ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Buoyant lipospheres; Lercanidipine hydrochloride; Modified melt dispersion technique

Indexed keywords

CETOSTEARYLIC ALCOHOL; LERCANIDIPINE; POLOXAMER;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; PARTICLE SIZE;

CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIHYDROPYRIDINES; DRUG EVALUATION, PRECLINICAL; MICROSPHERES; PARTICLE SIZE; X-RAY DIFFRACTION;

EID: 70449348660     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040802593908     Document Type: Article

References (20)

1. Acikgoz M, Kas HS, Hascelik Z, Milli U, Hincal AA. 1995. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. Pharmazie 50:275-277.
2. Babay D, Hoffman A, Benita S. 1998. Design and release kinetic pattern evaluation of indomethasin microspheres intended for oral administration. Biomaterials 9:428-488.
3. Cortesi R, Esposito E, Gambarin S, Telloli P, Menegatti E, Nastruzzi C. 1999. Preparation of liposomes by reverse-phase evaporation using alternative organic solvents. J Microencapsulation 16:251-256.
4. Davis SS. 1985. The design and evaluation of controlled release system for the gastrointestinal tract. J Contr Rel 2:27-38.
5. Desai S, Bolton S. 1993. A floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharm Res 10:1321-1325.
6. Deshpande AA, Rhodes CT, Shah NH, Malick AW. 1996. Controlledrelease drug delivery systems for prolonged gastric residence; an overview. Drug Dev Ind Pharm 22:531-539.
7. Fulzele SV, Satturwar PM, Kasliwal RH, Dorle AK. 2004. Preparation and evaluation of microcapsules using polymerized rosin as novel wall forming material. J Microencapsulation 21:83-89.
8. Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. 1998. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm 174:47-54. (Pubitemid 28486988)
9. Jenning V, Thunemann AF, Gohla SH. 2000. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167-177. (Pubitemid 30236188)
10. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. 1992. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 81:135-140.
11. Martin L, Wilson CG, Koosha F, Tetley L, Gray AI, Senel S, et al. 2002. The release of model macromolecules may be controlled by the hydrophobicity of palmitoylglycol chitosan hydrogels. J Contr Rel 80:87-100.
12. Miyagawa Y, Okabe T, Yamaguchi Y, Miyajima M, Sato H, Sunada H. 1996. Controlled-release of diclofenac sodium from wax matrix granule. Int J Pharm 138:215-224.
13. Oth M, Franz M, Timmermans J, Moës A. 1992. The bilayer floating capsule: A stomach-dried drug delivery system for misoprostol. Pharm Res 9:298-302.
14. Pandit SS, Hase DP, Bankar MM, Patil AT, Gaikwad NJ. 2008. Ketoprofenloaded Eudragit RSPO microspheres: An influence of sodium carbonate on in vitro drug release and surface topology. J Microencapsulation i-first:1-7.
15. Porter SC, Ghebre-Sellassie I, 1994. Key factors in the development of modified-release pellets. In: Ghebre-Sellassie I, editor. Multiparticulate oral drug delivery. New York: Marcel Dekker. pp 217-284.
16. Schwarz C, Mehnert W. 1999. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsulation 16:205-213.
17. Tandt LAGL, Stubbs C, Kanfer I. 1994. The use of dissolution rate to account for differences in the absorption profiles of two controlled/ modified-release capsule dosage forms of indomethasin in human volunteers. Int J Pharm 104:11-17.
18. Testa R, Leonardi A, Tajana A, Riscassi E, Magliocca R, Sartani A. 1997. Lercanidipine (Rec 15/2375): A novel 1,4-dihydropyridine calcium antagonist for hypertension. Cardiovasc Drug Rev 15:187-219.
19. Vyas SP, Singh R, Dimitrijevic D. 1997. Development and characterization of nifedipine lipospheres. Pharmazie 52:403-404.
20. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. 1998. An in vivo study demonstrating prolonged gastric retention. J Contr Rel 55:3-12.